Jul 4 |
Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
|
Jul 4 |
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
|
Jul 4 |
Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
|
Jul 4 |
FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
|
Jul 4 |
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
|
Jul 3 |
Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
|
Jul 3 |
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
|
Jul 3 |
Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
|
Jul 3 |
Weight-loss drugs linked to rare vision loss: Harvard study
|
Jul 3 |
ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
|